Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $43.8 million.

  • Acadia Healthcare Company's Cash from Financing Activities rose 2555.01% to $43.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $368.8 million, marking a year-over-year decrease of 2573.89%. This contributed to the annual value of $583.0 million for FY2024, which is 102989.78% up from last year.
  • According to the latest figures from Q3 2025, Acadia Healthcare Company's Cash from Financing Activities is $43.8 million, which was up 2555.01% from $57.5 million recorded in Q2 2025.
  • Acadia Healthcare Company's Cash from Financing Activities' 5-year high stood at $483.1 million during Q1 2024, with a 5-year trough of -$1.6 billion in Q1 2021.
  • In the last 5 years, Acadia Healthcare Company's Cash from Financing Activities had a median value of -$11.3 million in 2023 and averaged -$49.4 million.
  • Per our database at Business Quant, Acadia Healthcare Company's Cash from Financing Activities tumbled by 1216723.01% in 2021 and then skyrocketed by 436867.82% in 2024.
  • Acadia Healthcare Company's Cash from Financing Activities (Quarter) stood at $69.7 million in 2021, then tumbled by 124.83% to -$17.3 million in 2022, then surged by 67.31% to -$5.7 million in 2023, then skyrocketed by 1528.88% to $80.8 million in 2024, then tumbled by 45.76% to $43.8 million in 2025.
  • Its Cash from Financing Activities stands at $43.8 million for Q3 2025, versus $57.5 million for Q2 2025 and $186.7 million for Q1 2025.